A British woman has become the world’s first patient to trial the first ever natural cancer cure administered via a vaccine. The new vaccine has been designed to stimulate the body’s own immune system so that it destroys tumors that have spread in the body. 35-year-old Kelly Potter will trial the vaccine over the course of two years in an attempt to rid the cervical cancer she was diagnosed with in July 2015.
DARPA, the highly secretive arm of the Department of Defense, have launched various projects that will involve implanting microchips into soldiers’ brains – in an attempt to enhance battlefield performance and repair the traumatized minds of soldiers returning from war. “Of the 2.5 million Americans who served in Iraq and Afghanistan, 300,000 of them came home with traumatic brain injury,” author Annie Jacobsen told NPR. “DARPA initiated a series of programs to help cognitive functioning, to repair some of this damage.
Trading is was easy. Sleep in. Don't fight The Fed. Grab some lunch with friends. Then execute the following two trades...
For those used to the ubiquitous 330ET Ramp, there is some nuance that - if you were willing to make 2 trades, not just 1 each day - could have doubled your profits in the last 7 years.
Simple, and all that while taking no overnight exposure at all...
A company has created the first ever cannabis pill designed to relieve menstrual camp pain in women. Foria Relief have created a suppository that some are saying is more effective a pain relief than Ibuprofen, Midol, or Viodin. According to pill’s description: FORIA Relief has been carefully crafted using a delivery system intended to maximize the muscle relaxing and pain relieving properties of cannabis without inducing a psychotropic “high.” Cannabis has a long, cross-cultural history of use as a natural aid in easing symptoms associated with menstruation.
In a bid to promote a new Zika vaccine authorities are now claiming that the Zika virus may cause mental disorders and developmental disorders such as autism. Dr. W. Ian Lipkin, director of The Center for Infection and Immunity at Columbia University, told The New York Times, “I wouldn’t be surprised if we saw a big upswing in A.D.H.D., autism, epilepsy and schizophrenia,” in an interview about the potential consequences of the virus.